Is a Chiral method required? [Regulatives / Guidelines]

posted by xtianbadillo – Mexico, 2018-01-16 17:02 (1900 d 12:26 ago) – Posting: # 18185
Views: 3,257

A Clinical study is going to be with an enantiomer (not racemate).
The enantiomers exhibit different pharmacodynamic characteristics but only the active enantiomer is going to be in the formulation.
There is no in-vivo interconversion.
The reference standard is going to be the enantiomer (not racemate).

Is a chiral method required? Can I go with a simple achiral method?

Edit: Please follow the Forum’s Policy. [Helmut]

Complete thread:

UA Flag
 Admin contact
22,559 posts in 4,725 threads, 1,607 registered users;
11 visitors (0 registered, 11 guests [including 5 identified bots]).
Forum time: 06:29 CEST (Europe/Vienna)

The penalty for scientific irrelevance is, of course,
that the statistician’s work is ignored by the scientific community.    George E.P. Box

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz